Kite Pharma Secures $250,000 New Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=36bd192c-023b-4c8c-8f7d-35ac280d4f97&Preview=1 -
Date
12/14/2012 -
Company Name
Kite Pharma -
Mailing Address
10924 Le Conte Avenue Los Angeles, CA 90024 -
Company Description
Kite Pharma, Inc. is a privately held development stage biotechnology company engaged in the design and development of pioneering immune-based targeted therapies to treat different cancer indications. Kite has a portfolio of proprietary product candidates designed to stimulate the patient’s own immune system to fight tumor cells. -
Website
http://www.kitepharma.com -
Transaction Type
Debt, Venture Equity -
Transaction Amount
$250,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
